CarolynBennettHendricksMDFASCO

Oncology • Bethesda, MD

Breast medical oncology

Join to view full profile

Dr. Hendricks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hendricks' full profile

Already have an account?

Office
6410 Rockledge Dr
Ste 506
Bethesda, MD 20817
Phone+1 301-897-1503

Fax+1 301-581-0254

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1988
Johns Hopkins University School of MedicineClass of 1985

Certifications & Licensure

MD State Medical License 1988 - 2026
NJ State Medical License 2014 - 2015
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Molecular Genetics Studies of Cancer Patients and Their Relatives Start of enrollment: 1997 Apr 18
Recruiting
Join now to see all

Publications & Presentations

PubMed

48 citations
Double-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (...
Kathy D. Miller, Anne O'Neill, William J. Gradishar, Timothy J. Hobday, Lori J. Goldstein
Journal of Clinical Oncology. 2018-07-24
34 citations
2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology.
Michael N. Neuss, Terry Gilmore, Kristin M. Belderson, Amy L. Billett, Tara Conti-Kalchik
Journal of Oncology Practice. 2016-11-21
43 citations
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response ...
Denise A. Yardley, N. W. Peacock, Mythili Shastry, Howard A. Burris, Rebecca Bechhold
Breast Cancer Research and Treatment. 2015-10-27

Press Mentions

Shop TalkJanuary 5th, 2021
Carolyn Hendricks, MD, FASCO, Named ASCO Advocate of the YearSeptember 16th, 2020
Federal Funding Is Critical to Continuing Progress Against Cancer, ASCO Tells CongressOctober 30th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member